About ActiveCure
ActiveCure is a company based in Hyderabad (India). ActiveCure offers products and services including UHV Pain Management Device and U-Gel Herbal Medicated Ultrasound Gel.
- Headquarter Hyderabad, India
- SectorsHealthcare
- Email••••••••
- Legal Name Satvaayush Technologies Pvt. Ltd
- Date of Incorporation 22 May, 2019
- Jurisdiction North Solapur, Maharashtra, India
- Annual Revenue₹1.5 Lakh
FY 2026 · +20% YoY
- Net Loss-₹1.5 Lakh
FY 2026 · -104% margin
- EBITDA-₹1.5 Lakh
FY 2026 · -104% margin
Associated legal entities of ActiveCure
ActiveCure operates through Satvaayush Technologies Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Satvaayush Technologies Private Limited CIN U33100PN2019PTC184273 | Active | 22 May 2019 | North Solapur, Maharashtra | ₹0.0 Cr | – | 3 | View details |
Products & Services of ActiveCure
ActiveCure offers a comprehensive portfolio of products and services, including UHV Pain Management Device and U-Gel Herbal Medicated Ultrasound Gel.
A device is used for pain management that enhances blood flow and deep tissue temperature in treated areas
A gel is applied for ultrasound procedures, enriched with natural herbs to provide soothing effects and conductivity
Board of directors of Satvaayush Technologies Private Limited (ActiveCure)
Satvaayush Technologies Private Limited is the primary company behind ActiveCure. The board of Satvaayush Technologies Private Limited currently have 3 directors; the longest-serving is Raghunandan Krishna Bhakta, appointed in 2019.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Raghunandan Krishna Bhakta DIN 08450729 | Director | 22 May 2019 | 7 yrs 4 mo | Satvaayush Technologies Private Limited |
| Nagarajurao Pinjala Basaveshwarrao DIN 08450730 | Director | 22 May 2019 | 7 yrs 4 mo | Satvaayush Technologies Private Limited |
| Tikam Sujan DIN 02137651 | Director | 01 Jul 2019 | 7 yrs 3 mo | Satvaayush Technologies Private Limited |
Financials of ActiveCure
Figures of Satvaayush Technologies Private Limited, the primary company behind ActiveCure, for FY 2026. Revenue was ₹1.5 Lakh (+20% year on year). Net loss was -₹1.5 Lakh (-104% margin). EBITDA was -₹1.5 Lakh (-104% margin). Revenue has grown at a compounded annual rate of -13% over three years and -20% over five years.
- ₹1.5 LakhRevenue · FY 2026 · +20% YoY
- -₹1.5 LakhNet loss · -104% margin
- -₹1.5 LakhEBITDA · -104% margin
- ₹8.5 LakhPaid-up capital
- -13%Revenue CAGR, 3 years
- -20%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Satvaayush Technologies Private Limited are on its company page.
Detailed financial statements for ActiveCure
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to ActiveCure
10 companies that operate in the same segment as ActiveCure (Pain Management), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
Developer of therapeutics for pain relief and inflammatory diseases | 2004 | New York, New York, United States | USD 51 M | USD 4.33 M | 79 | |
GPCR ligand-based therapeutics for cardiovascular diseases and pain are developed. | 2007 | Philadelphia, Pennsylvania, United States | USD 203 M | USD 3.13 M | 35 | |
Therapeutics for migraine treatment are developed using nasal delivery. | 2016 | San Francisco, California, United States | USD 74.13 M | – | 24 | |
Pain treatment products are developed through reformulation technologies. | 2007 | Herzliya, Central District, Israel | USD 12 M | USD 17 K | 6 | |
Drug delivery systems for CNS disorders and pain are developed. | 2006 | Emeryville, California, United States | USD 149.06 M | – | – | |
Developer of neuromodulation platform measuring biomarkers for chronic neurological condition treatment | 2010 | Bloomington, Indiana, United States | USD 530 M | USD 91.65 M | – | |
Therapies for pain and addiction treatment are developed. | 1977 | Saint-cloud, France | USD 248.09 M | USD 167.87 M | – | |
Novel drug products for chronic pain treatment are developed. | 2007 | Blue Bell, Pennsylvania, United States | USD 12.96 M | – | 17 | |
Abuse-deterrent extended-release therapeutics for chronic pain are developed. | 2002 | Canton, Ohio, United States | USD 103 M | USD 780.57 M | 357 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ActiveCure
ActiveCure is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
The primary company behind ActiveCure, Satvaayush Technologies Private Limited, reported revenue of ₹1.5 Lakh for FY 2026, up 20% year on year.
ActiveCure is identified as a brand that operates under Satvaayush Technologies Pvt. Ltd., where physiotherapy devices and physiocare products for pain management are developed and manufactured. These products are designed to address pain points through methods that enhance blood flow and minimize opioid use. The entity is managed by technocrats from India and the USA, who bring over 50 years of combined experience in the field. Offerings include pain management devices, herbal gels, and pain relief oils, which are utilized in various treatment sessions to support patient care. A total of over 500,000 happy patients and 2,000,000 treatment sessions have been reported, indicating the reach of these solutions.
ActiveCure offers UHV Pain Management Device and U-Gel Herbal Medicated Ultrasound Gel.
ActiveCure operates through Satvaayush Technologies Private Limited.
The legal entities of ActiveCure currently have 3 directors, including Raghunandan Krishna Bhakta, Nagarajurao Pinjala Basaveshwarrao, Tikam Sujan.